Daniel Feikin
 |
Daniel Feikin is a recognized expert on the epidemiology of infectious diseases in developing countries. He currently serves as Director of Epidemiology at the International Vaccine Access Center (IVAC), an organization dedicated to accelerating global access to life-saving vaccines, at The Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland.
Education
Dr. Feikin earned his Medical Degree at Harvard Medical School in Boston, MA. He earned his Master of Science in Public Health from the University of Colorado Health Sciences Center and his Bachelors degree from Yale University in New Haven, CT.
Research
After completing his residency in Internal Medicine, Dr. Feikin worked for the Centers for Disease Control and Prevention (CDC), first as an Epidemic Intelligence Service Officer for 2 years and then as a Medical Epidemiologist in the Respiratory Disease Branch in the Division of Bacterial and Mycotic Diseases for 4 years. While at the CDC, Dr. Feikin’s subject matter concentration was on respiratory bacteria, particularly accelerating and evaluating the impact of vaccines for Haemophilus influenzae type b and Streptococcus pneumoniae. In 2004, Dr. Feikin served as Epidemiology Section Chief for the International Emerging Infections Program in Kenya. In that role, he conducted outbreak investigations of infectious diseases in Kenya (cholera, meningococcal meningitis, Rift Valley Fever, Brucella, Typhoid Fever), coordinated longitudinal, population-based surveillance for infectious diseases in rural and urban Kenya, coordinated health aspects of Demographic Surveillance System, and was a principal investigator on clinical trials of rotavirus vaccine and home zinc treatment for diarrhea.
Currently, at IVAC Dr. Feikin has been developing the Pneumonia Etiology Research for Child Health (PERCH) project, which is funded by a 43 million dollar grant from the Bill and Melinda Gates Foundation. The PERCH research study aims to identify etiology of severe pneumonia in children in developing countries in the post-Hib/pneumococcal vaccine era. Dr. Feikin is the lead on the clinical/epidemiology team. Dr. Feikin also is the principal investigator at IVAC on a systematic review of available data on the issue of serotype replacement after introduction of pneumococcal conjugate vaccines. The results of this project will contribute to a new WHO position paper on pneumococcal vaccines for developing countries. Dr. Feikin is also working on the Accelerated Vaccine Initiative to evaluate the impact of introduction of pneumococcal conjugate, Haemophilus influenza type b and rotavirus vaccines in the world’s poorest countries.[1]
Dr. Feikin has co-authored over 70 peer-reviewed publications, several dozen non-peer-reviewed publications and 2 book chapters.
Honors and Awards
| 1987 | Yale University: summa cum laude; Phi Beta Kappa;
Allan Bateman Prize for Outstanding Science Student in Silliman College; William B. Belknap Prize for Excellence in Biology; Silliman College Student Marshall |
| 1998 | Mackel Award finalist, first author. EIS conference, Atlanta, Georgia |
| 2000 | Mackel Award finalist, co-author. EIS conference, Atlanta, Georgia |
| 2004 | James H. Nakano citation. Outstanding scientific paper published in 2003. National Center for Infectious Diseases, CDC |
| 2004 | 2004 NCEH/ATSDR Honor Award for Excellence in Global Efforts. Aflatoxin Outbreak. |
| 2006 | James H. Nakano citation. Outstanding scientific paper published in 2003. National Center for Infectious Diseases, CDC |
| 2006 | Charles C. Shepard Science Award for Scientific Excellence demonstrated by publication of Paper on effect of handwashing on child health. CDC. |
| 1996-present | US Public Health Service awards include Achievement Medal (2), Citation (1), Outstanding Unit Commendation (1), Unit Commendation (2), Outstanding Unit citation (2), Crisis Response Service Award (1), Foreign Duty Award (2), Outstanding Service Medal (1) |
References
- ^ http://www.jhsph.edu/ivac.
{{cite web}}: Missing or empty|title=(help)